United States · FDA National Drug Code directory
cetirizine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-207_517ed467-a0d0-43ab-99ce-e6a4808800c4
- Product NDC
- 71205-207
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071227
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (71205-207-06) · 71205-207-06
- 10 TABLET in 1 BOTTLE (71205-207-10) · 71205-207-10
- 15 TABLET in 1 BOTTLE (71205-207-15) · 71205-207-15
- 30 TABLET in 1 BOTTLE (71205-207-30) · 71205-207-30
- 60 TABLET in 1 BOTTLE (71205-207-60) · 71205-207-60
- 90 TABLET in 1 BOTTLE (71205-207-90) · 71205-207-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →